A Study of LY2409021 in Participants With Type 2 Diabetes Mellitus
Status:
Terminated
Trial end date:
2015-09-01
Target enrollment:
Participant gender:
Summary
The intent of this study is to assess the safety of LY2409021 in participants with Type 2
diabetes mellitus taking metformin and sulfonylurea as prescribed by their personal
physician. The study treatment is expected to last 12 months (52 weeks).